CU20120065A7 - Derivado de 4-[etil(dimetil)amonio] butanoato para el tratamiento de enfermedades cardiovasculares y sus métodos de obtención - Google Patents

Derivado de 4-[etil(dimetil)amonio] butanoato para el tratamiento de enfermedades cardiovasculares y sus métodos de obtención

Info

Publication number
CU20120065A7
CU20120065A7 CUP2012000065A CU20120065A CU20120065A7 CU 20120065 A7 CU20120065 A7 CU 20120065A7 CU P2012000065 A CUP2012000065 A CU P2012000065A CU 20120065 A CU20120065 A CU 20120065A CU 20120065 A7 CU20120065 A7 CU 20120065A7
Authority
CU
Cuba
Prior art keywords
butanoate
dimethyl
ammonium
ethyl
methods
Prior art date
Application number
CUP2012000065A
Other languages
English (en)
Other versions
CU24114B1 (es
Inventor
Ivars Kalvins
Maija Dambrova
Edgars Liepins
Osvalds Pugovics
Reinis Vilskersts
Janis Kuka
Solvita Grinberga
Einars Loza
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Publication of CU20120065A7 publication Critical patent/CU20120065A7/es
Publication of CU24114B1 publication Critical patent/CU24114B1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a un nuevo compuesto 4-[etil(dimetil)amonio]butanoato y los métodos de preparación del mismo, dicho compuesto de fórmula: ESPACIO PARA LA FÓRMULA Se describen cuatro métodos para la obtención del compuesto deseado 4-[etil(dimetil)amonio]butanoato. El compuesto 4-[etil(dimetil)amonio]butanoato tiene un efecto cardioprotector pronunciado, por lo que es de utilidad en el tratamiento de enfermedades cardiovasculares.
CUP2012000065A 2009-10-22 2012-04-23 Derivado de 4-[etil(dimetil)amonio] butanoato para el tratamiento de enfermedades cardiovasculares y sus métodos de obtención CU20120065A7 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LVP-09-181A LV14345B (lv) 2009-10-22 2009-10-22 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai
PCT/EP2010/065924 WO2011048201A1 (en) 2009-10-22 2010-10-22 Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease

Publications (2)

Publication Number Publication Date
CU20120065A7 true CU20120065A7 (es) 2012-06-29
CU24114B1 CU24114B1 (es) 2015-08-27

Family

ID=43530044

Family Applications (1)

Application Number Title Priority Date Filing Date
CUP2012000065A CU20120065A7 (es) 2009-10-22 2012-04-23 Derivado de 4-[etil(dimetil)amonio] butanoato para el tratamiento de enfermedades cardiovasculares y sus métodos de obtención

Country Status (33)

Country Link
US (2) US9278907B2 (es)
EP (1) EP2491005B1 (es)
JP (1) JP5552169B2 (es)
KR (1) KR101355417B1 (es)
CN (1) CN102666476B (es)
AR (1) AR081514A1 (es)
AU (1) AU2010309756B2 (es)
BR (1) BR112012009162B8 (es)
CA (1) CA2781499C (es)
CL (1) CL2012001010A1 (es)
CO (1) CO6531459A2 (es)
CU (1) CU20120065A7 (es)
DK (1) DK2491005T3 (es)
EA (1) EA020303B1 (es)
ES (1) ES2508117T3 (es)
GE (1) GEP20146123B (es)
HK (1) HK1169824A1 (es)
HR (1) HRP20140964T1 (es)
IL (1) IL219217A0 (es)
LV (1) LV14345B (es)
ME (1) ME01917B (es)
MX (1) MX2012004630A (es)
NZ (1) NZ599521A (es)
PE (1) PE20121473A1 (es)
PL (1) PL2491005T3 (es)
PT (1) PT2491005E (es)
RS (1) RS53620B1 (es)
SI (1) SI2491005T1 (es)
SM (1) SMT201400176B (es)
TN (1) TN2012000174A1 (es)
UA (1) UA107201C2 (es)
WO (1) WO2011048201A1 (es)
ZA (1) ZA201202916B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8565150B2 (en) * 2009-03-11 2013-10-22 At&T Mobility Ii Llc Architectural model for LTE (long term evolution) EPC (evolved packet core) deployment
US20140088125A1 (en) * 2011-04-27 2014-03-27 Jsc Grindeks Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
DE102012109911A1 (de) 2011-10-19 2013-04-25 Electronics And Telecommunications Research Institute Energy harvesting device using electromagnetic interference signal and sensor system including the same
JO3117B1 (ar) * 2012-12-20 2017-09-20 Grindeks Jsc استعمال 3- كربوكسي- ن-إيثيل- ن، ن- ثاني ميثيل بروبان-1– أمينيوم أو ملح منه مقبول صيدلانياً في معالجة تصلب الشرايين
JO3333B1 (ar) * 2013-09-26 2019-03-13 Grindeks Jsc استعمال 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium أو ملح مقبول دوائيا منه للوقاية من السكري وعلاجه
CN107879944B (zh) * 2017-10-30 2020-05-22 杭州海尔希畜牧科技有限公司 一种制备丁基甜菜碱的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1238868A (es) 1967-08-08 1971-07-14
SU997646A1 (ru) 1978-11-27 1983-02-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Кормова добавка
IT1210935B (it) 1981-09-17 1989-09-29 Inst Orch Sinteza Akademi Nauk Composizione farmaceutica per il trattamento di malattie cardiovascolari.
IT1190280B (it) * 1986-04-24 1988-02-16 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di gamma-butirrobetaina
US4933103A (en) * 1987-03-23 1990-06-12 Kao Corporation Bleaching composition
SU1680693A1 (ru) * 1987-03-25 1991-09-30 Институт Органического Синтеза Ан Латвсср Этил-3-(2,2-диметил-2-этилгидразиний)пропионат иодистый, про вл ющий антиаритмическую активность
JPH0291049A (ja) * 1988-09-21 1990-03-30 Lonza Ag ｒ―ブチロベタインの製造方法
JP3119430B2 (ja) * 1995-07-25 2000-12-18 大鵬薬品工業株式会社 水酸基ラジカル消去剤
LV11728B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition
US5973026A (en) 1998-02-02 1999-10-26 Xerox Corporation Ink jet inks
JP2000239239A (ja) * 1999-02-22 2000-09-05 Kankyo Meneki Gijutsu Kenkyusho:Kk クロルメコート類縁化合物のハプテン化合物、抗体及び測定方法
CA2508094A1 (en) 2005-05-20 2006-11-20 Vivier Canada Inc. Composition for accelerating collagen synthesis
US7863274B2 (en) 2005-07-29 2011-01-04 Concert Pharmaceuticals Inc. Deuterium enriched analogues of tadalafil as PDE5 inhibitors
LV13705B (en) 2006-11-06 2008-07-20 Ivars Kalvins Process for producing high purity intermolecular salt of 3-carboxy-n,n,n-trimethyl-propane-1-amine hydroxide
JP4761265B2 (ja) 2007-10-17 2011-08-31 学校法人甲南学園 核酸合成を促進する化合物を含む組成物およびその利用、並びに当該化合物の製造方法
CN101538214A (zh) * 2009-04-24 2009-09-23 潍坊祥维斯化学品有限公司 生产γ-丁基甜菜碱及其盐酸盐的方法
WO2012146737A1 (en) * 2011-04-27 2012-11-01 Grindeks, A Joint Stock Company 4-[(haloalkyl)(dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular disease

Also Published As

Publication number Publication date
BR112012009162B8 (pt) 2021-07-27
BR112012009162B1 (pt) 2021-02-02
US9573882B2 (en) 2017-02-21
CA2781499A1 (en) 2011-04-28
RS53620B1 (en) 2015-04-30
JP5552169B2 (ja) 2014-07-16
SMT201400176B (it) 2015-01-15
NZ599521A (en) 2013-11-29
CU24114B1 (es) 2015-08-27
IL219217A0 (en) 2012-06-28
BR112012009162A2 (pt) 2020-08-18
US9278907B2 (en) 2016-03-08
ME01917B (me) 2015-05-20
US20120220656A1 (en) 2012-08-30
CN102666476A (zh) 2012-09-12
LV14345A (lv) 2011-05-20
WO2011048201A1 (en) 2011-04-28
AR081514A1 (es) 2012-10-03
CO6531459A2 (es) 2012-09-28
LV14345B (lv) 2011-07-20
PE20121473A1 (es) 2012-11-18
CN102666476B (zh) 2014-07-09
EA201200514A1 (ru) 2012-09-28
EP2491005A1 (en) 2012-08-29
EP2491005B1 (en) 2014-07-23
HRP20140964T1 (hr) 2014-12-05
MX2012004630A (es) 2013-07-29
CA2781499C (en) 2015-03-24
HK1169824A1 (en) 2013-02-08
SI2491005T1 (sl) 2014-12-31
UA107201C2 (uk) 2014-12-10
PT2491005E (pt) 2014-10-29
ZA201202916B (en) 2013-05-29
CL2012001010A1 (es) 2012-08-31
AU2010309756A1 (en) 2012-05-17
JP2013508342A (ja) 2013-03-07
ES2508117T3 (es) 2014-10-16
AU2010309756B2 (en) 2013-10-17
EA020303B1 (ru) 2014-10-30
TN2012000174A1 (en) 2013-12-12
KR20120101634A (ko) 2012-09-14
DK2491005T3 (da) 2014-10-27
US20160137589A1 (en) 2016-05-19
PL2491005T3 (pl) 2015-03-31
KR101355417B1 (ko) 2014-01-27
GEP20146123B (en) 2014-07-25

Similar Documents

Publication Publication Date Title
UY33735A (es) Compuestos antivirales
BR112014030473A2 (pt) novo diazaespirocicloalcano e azaespirocicloalcano
EA201490567A1 (ru) Новые бициклические производные дигидрохинолин-2-она
BRPI1012638B8 (pt) métodos e intermediários para preparar agentes farmacêuticos
BR112015004111A2 (pt) novos derivados bicíclicos
CR20120264A (es) Compuestos
CL2014000630A1 (es) Una composicion que comprende 1) un compuesto derivado de nucleosido denominado como compuesto 10 y 2) un compuesto derivado de acido 5-tiofeno-2-carboxilico denominado como compuesto 5 o un compuesto derivado del ester metilico del acido carbamico denominado como compuesto 6; y su uso para el tratamiento profilactico o terapeutico de una infeccion por vhc.
UA111626C2 (uk) Похідні дигідрохінолін-2-ону
GT201200230A (es) Inhibidores del virus de la hepatitis c
CY1122670T1 (el) Παρασκευη παρασκευασματος και παρασκευασμα που περιλαμβανει αναστολεα μεκ
BR112014030365A2 (pt) síntese de composto antiviral
ECSP11011517A (es) Compuestos antivirales
EA202190619A1 (ru) Противовирусные соединения
CU20120065A7 (es) Derivado de 4-[etil(dimetil)amonio] butanoato para el tratamiento de enfermedades cardiovasculares y sus métodos de obtención
BR112014018756A8 (pt) Processo para preparo de etil éster de ácido n-(4-ciclo-hexil-3-trifluorometil-benziloxi)-acetimídico
UY32077A (es) Inhibidores de quinasa tipo polo
CR20140071A (es) Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa
CO6420341A2 (es) Herbicidas novedosos
ECSP14004595A (es) 2-tiopirimidinonas
EA201490846A1 (ru) Новые производные арилхинолина
BR112013018732A2 (pt) novos derivados de amida de aril-benzocicloalquila
CR20140078A (es) Compuestos de benzofurano para el tratamiento de infecciones por el virus de hepatitis c (hcv)
CO6321288A2 (es) Sales de compuestos inhibidores de vih
EA201101675A1 (ru) Спироэпоксиды как промежуточные продукты синтеза
CO6590210A1 (es) Complejo obtenido a partir de mezclas de ácido hialurónico o una sal del mismo y sulfato de condroitina

Legal Events

Date Code Title Description
FG Grant of patent